Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Cure of Multidrug-Resistant Acinetobacter baumannii FixationDevice-Related Orthopedic Infections in Two Patients withIntravenous Colistin
2005
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
2003
Knowledge-based interpretation of sensor patterns
1992
Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production
2014
Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin
2007
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
2013 Standout
Simultaneous determination of paracetamol and dextropropoxyphene in human plasma by liquid chromatography/tandem mass spectrometry: application to clinical bioequivalence studies
2005
In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii
2006
Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate
2004
fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
2010
Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries
2015
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
2005 Standout
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine.
1992
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
The metabolic syndrome
2010 Standout
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
The Degradation of Apolipoprotein B100 Is Mediated by the Ubiquitin-proteasome Pathway and Involves Heat Shock Protein 70
1997 StandoutNobel
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence
2006
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Metabolite Profiling Identifies Markers of Uremia
2010
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic
2005
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
The metabolic syndrome
2005 Standout
Structure-antioxidant activity relationships of flavonoids and phenolic acids
1996 Standout
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster
2007
Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis
2003
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
The enhanced permeability retention effect: a new paradigm for drug targeting in infection
2012
Eye movements in reading and information processing: 20 years of research.
1998 Standout
The phenolic compounds of olive oil: structure, biological activity and beneficial effects on human health
2005
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Siccanin Rediscovered as a Species-Selective Succinate Dehydrogenase Inhibitor
2009 StandoutNobel
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii
2007
A Bioorthogonal Reaction of N‐Oxide and Boron Reagents
2015 StandoutNobel
AKT/PKB Signaling: Navigating the Network
2017 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Intravenous Colistin for the Treatment of Multi-Drug Resistant, Gram-Negative Infection in the Pediatric Burn Population
2007
The role of oxidized lipoproteins in atherogenesis
1996
Pharmacokinetic issues for antibiotics in the critically ill patient
2009
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
2007
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)
2006
Improving antibiotic dosing in special situations in the ICU
2012
Metabolomic profiling of uremic solutes in CKD patients
2010
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Polymyxin B Identified as an Inhibitor of Alternative NADH Dehydrogenase and Malate: Quinone Oxidoreductase from the Gram-positive Bacterium Mycobacterium smegmatis
2009 StandoutNobel
The clinical use of colistin in patients with cystic fibrosis
2001
Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin
2006
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study
2005
Inflammasomes in health and disease
2012 StandoutNature
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
1992 Standout
Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients
2004
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Computing with Neural Circuits: A Model
1986 StandoutScienceNobel
Analytical Redundancy Methods in Fault Detection and Isolation - Survey and Synthesis
1991
On-line fault diagnosis using the signed directed graph
1990
Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1–bla OXA-23 genes in a Chinese hospital
2007
The contributory role of gut microbiota in cardiovascular disease
2014
Performance-based health monitoring, diagnostics and prognostics for condition-based maintenance of gas turbines: A review
2017 Standout
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
2006
Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis
2005
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Resolution of syntactic category ambiguities: Eye movements in parsing lexically ambiguous sentences
1987
Novel Polymyxin Derivatives Carrying Only Three Positive Charges Are Effective Antibacterial Agents
2008
Fault diagnosis in dynamic systems using analytical and knowledge-based redundancy
1990 Standout
Analysis of major components of residual bacitracin and colistin in food samples by liquid chromatography tandem mass spectrometry
2004
Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
2012
Colistin Methanesulfonate against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model
2007
Polymyxin antibiotics for gram-negative infections
2007
Recent Advances in Electrocatalytic Hydrogen Evolution Using Nanoparticles
2019 Standout
Prevention of venous thromboembolism after general surgery
1987
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England
2006
Meat consumption, health, and the environment
2018 StandoutScience
Bimetallic PtPd alloyed core-shell nanodendrites supported on reduced graphene oxide: One-pot green synthesis and efficient electrocatalytic performances for glycerol oxidation and hydrogen evolution
2017
Low-Molecular-Weight Heparins
1997 Standout
The Response-to-Retention Hypothesis of Early Atherogenesis
1995
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Synergistic Activity of Colistin and Ceftazidime against Multiantibiotic-Resistant Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model
2003
Data Mining: Practical Machine Learning Tools and Techniques
2011 Standout
Synthetic Riboswitches That Induce Gene Expression in Diverse Bacterial Species
2010 StandoutNobel
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
A Cost-effectiveness Analysis of Prophylaxis Against Deep-Vein Thrombosis in Major Orthopedic Surgery
1987
Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
2006
Chiral drugs: an overview.
2006
Pruning Decision Trees and Lists
2000
Sulfur(VI) Fluoride Exchange (SuFEx)-Enabled High-Throughput Medicinal Chemistry
2020 StandoutNobel
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma
1995
A review of process fault detection and diagnosis
2003 Standout
Signalling to eIF4E in cancer
2015
Massively Parallel Parsing: A Strongly Interactive Model of Natural Language Interpretation*
1985
Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant Acinetobacter baumannii
2002
Comparative Evaluation of the VITEK 2, Disk Diffusion, Etest, Broth Microdilution, and Agar Dilution Susceptibility Testing Methods for Colistin in Clinical Isolates, Including Heteroresistant Enterobacter cloacae and Acinetobacter baumannii Strains
2007
Cost-effectiveness of Enoxaparin vs Low-Dose Warfarin in the Prevention of Deep-Vein Thrombosis After Total Hip Replacement Surgery
1995
Works of Robert Milne being referenced
An explanation for minimal attachment and right association
1982
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
2004
Enantioselective assay for the determination of perhexiline enantiomers in human plasma by liquid chromatography
2006
The quantification of paracetamol, paracetamol glucuronide and paracetamol sulphate in plasma and urine using a single high-performance liquid chromatography assay
2003
Pharmacokinetic Drug Interactions with Phenytoin (Part II)
1990
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
2006
Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis
2006
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
2008
Pharmacokinetic Drug Interactions with Phenytoin (Part I)1
1990
Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3H)‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation
2014
A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography
2001
TIGER ™ : continuous diagnosis of gas turbines
2000
Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity againstPseudomonas aeruginosain Murine Thigh and Lung Infection Models
2009
Use of High-Performance Liquid Chromatography To Study the Pharmacokinetics of Colistin Sulfate in Rats following Intravenous Administration
2003
Organ perfusion techniques in drug development
1999
Research and Development in Expert Systems IX
1993
Stability of Colistin and Colistin Methanesulfonate in Aqueous Media and Plasma as Determined by High-Performance Liquid Chromatography
2003
Predicting Garden Path Sentences*
1982
Renal Disposition of Colistin in the Isolated Perfused Rat Kidney
2009
Simple Method for Assaying Colistin Methanesulfonate in Plasma and Urine Using High-Performance Liquid Chromatography
2002
Subacute Toxicity of Colistin Methanesulfonate in Rats: Comparison of Various Intravenous Dosage Regimens
2008
Predicting garden path sentences
1982
Strategies for Diagnosis
1987
Cu2(+)-mediated oxidation of dialyzed plasma: effects on low and high density lipoproteins and cholesteryl ester transfer protein.
1991
Discovery of (E)-3-((Styrylsulfonyl)methyl)pyridine and (E)-2-((Styrylsulfonyl)methyl)pyridine Derivatives as Anticancer Agents: Synthesis, Structure–Activity Relationships, and Biological Activities
2014
Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition.
1991
In Vitro Pharmacodynamic Properties of Colistin and Colistin Methanesulfonate against Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis
2001
Oral L-Carnitine: Metabolite Formation and Hemodialysis
2006